Cyclophilin D-mediated regulation of the permeability transition pore is altered in mice lacking the mitochondrial calcium uniporter.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 22 03 2018
accepted: 22 08 2018
pubmed: 31 8 2018
medline: 7 3 2020
entrez: 31 8 2018
Statut: ppublish

Résumé

Knockout (KO) of the mitochondrial Ca2+ uniporter (MCU) in mice abrogates mitochondrial Ca2+ uptake and permeability transition pore (PTP) opening. However, hearts from global MCU-KO mice are not protected from ischaemic injury. We aimed to investigate whether adaptive alterations occur in cell death signalling pathways in the hearts of global MCU-KO mice. First, we examined whether cell death may occur via an upregulation in necroptosis in MCU-KO mice. However, our results show that neither RIP1 inhibition nor RIP3 knockout afford protection against ischaemia-reperfusion injury in MCU-KO as in wildtype (WT) hearts, indicating that the lack of protection cannot be explained by upregulation of necroptosis. Instead, we have identified alterations in cyclophilin D (CypD) signalling in MCU-KO hearts. In the presence of a calcium ionophore, MCU-KO mitochondria take up calcium and do undergo PTP opening. Furthermore, PTP opening in MCU-KO mitochondria has a lower calcium retention capacity (CRC), suggesting that the calcium sensitivity of PTP is higher. Phosphoproteomics identified an increase in phosphorylation of CypD-S42 in MCU-KO. We investigated the interaction of CypD with the putative PTP component ATP synthase and identified an approximately 50% increase in this interaction in MCU-KO cardiac mitochondria. Mutation of the novel CypD phosphorylation site S42 to a phosphomimic reduced CRC, increased CypD-ATP synthase interaction by approximately 50%, and increased cell death in comparison to a phospho-resistant mutant. Taken together these data suggest that MCU-KO mitochondria exhibit an increase in phosphorylation of CypD-S42 which decreases PTP calcium sensitivity thus allowing activation of PTP in the absence of an MCU-mediated increase in matrix calcium.

Identifiants

pubmed: 30165576
pii: 5079902
doi: 10.1093/cvr/cvy218
pmc: PMC6657279
doi:

Substances chimiques

Calcium Channels 0
Mcu protein, mouse 0
Mitochondrial Membrane Transport Proteins 0
Mitochondrial Permeability Transition Pore 0
Mitochondrial Proteins 0
Receptor-Interacting Protein Serine-Threonine Kinases EC 2.7.11.1
Ripk3 protein, mouse EC 2.7.11.1
Cyclophilins EC 5.2.1.-
PPID protein, human EC 5.2.1.8
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

385-394

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL142589
Pays : United States
Organisme : NHLBI NIH HHS
ID : ZIA HL002066
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

J Physiol. 2017 Jun 15;595(12):3743-3751
pubmed: 27991671
Cardiovasc Res. 2014 Jul 15;103(2):206-16
pubmed: 24920296
Annu Rev Physiol. 2007;69:51-67
pubmed: 17007587
J Proteome Res. 2009 Oct;8(10):4665-75
pubmed: 19694452
J Natl Cancer Inst. 2015 Feb 03;107(3):
pubmed: 25650317
Cell Rep. 2015 Jul 7;12(1):15-22
pubmed: 26119742
Nature. 2005 Mar 31;434(7033):658-62
pubmed: 15800627
J Biol Chem. 1997 Aug 22;272(34):21104-12
pubmed: 9261114
J Biol Chem. 2010 Mar 26;285(13):9535-44
pubmed: 20042608
J Exp Med. 2000 Oct 2;192(7):1001-14
pubmed: 11015441
Mol Cell Biol. 2004 Feb;24(4):1464-9
pubmed: 14749364
J Biol Chem. 2014 Jun 6;289(23):15980-5
pubmed: 24790105
J Mol Cell Cardiol. 2015 Aug;85:178-82
pubmed: 26057074
J Biol Chem. 2011 Nov 18;286(46):40184-92
pubmed: 21930693
Cardiovasc Res. 1993 Oct;27(10):1790-4
pubmed: 8275525
Cell Death Differ. 2016 Jan;23(1):1-2
pubmed: 26586571
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):9129-34
pubmed: 26153425
Biophys J. 2001 Dec;81(6):3275-84
pubmed: 11720991
Nat Rev Mol Cell Biol. 2014 Feb;15(2):135-47
pubmed: 24452471
Nat Cell Biol. 2018 Feb;20(2):186-197
pubmed: 29358703
PLoS One. 2015 Jun 10;10(6):e0130520
pubmed: 26061004
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):726-31
pubmed: 20080742
Nature. 2011 Jun 19;476(7360):336-40
pubmed: 21685888
J Mol Cell Cardiol. 1993 Dec;25(12):1461-9
pubmed: 7512654
Nat Cell Biol. 2013 Dec;15(12):1464-72
pubmed: 24212091
Biochemistry. 2012 Apr 10;51(14):2959-73
pubmed: 22443365
Biochim Biophys Acta. 2009 Dec;1787(12):1486-91
pubmed: 19616504
Stem Cells Transl Med. 2017 Feb;6(2):527-538
pubmed: 28191759
Arch Biochem Biophys. 1979 Jul;195(2):453-9
pubmed: 383019
Nat Med. 2016 Feb;22(2):175-82
pubmed: 26726877
Sci Rep. 2015 Jun 11;5:11319
pubmed: 26066579
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12024-9
pubmed: 23818611
Aging (Albany NY). 2010 Dec;2(12):914-23
pubmed: 21212461
Nature. 2011 Jun 19;476(7360):341-5
pubmed: 21685886
J Biol Chem. 2009 Dec 4;284(49):33982-8
pubmed: 19801635
Cell Rep. 2015 Jul 7;12(1):23-34
pubmed: 26119731
FEBS Lett. 2002 Feb 13;512(1-3):1-7
pubmed: 11852041

Auteurs

Randi J Parks (RJ)

Cardiovascular Branch, NHLBI, NIH, 10 Center Drive Bethesda, MD, USA.

Sara Menazza (S)

Cardiovascular Branch, NHLBI, NIH, 10 Center Drive Bethesda, MD, USA.

Kira M Holmström (KM)

Center for Molecular Medicine, NHLBI, NIH, Bethesda, MD, USA.

Georgios Amanakis (G)

Cardiovascular Branch, NHLBI, NIH, 10 Center Drive Bethesda, MD, USA.

Maria Fergusson (M)

Cardiovascular Branch, NHLBI, NIH, 10 Center Drive Bethesda, MD, USA.

Hanley Ma (H)

Cardiovascular Branch, NHLBI, NIH, 10 Center Drive Bethesda, MD, USA.

Angel M Aponte (AM)

Center for Molecular Medicine, NHLBI, NIH, Bethesda, MD, USA.

Paolo Bernardi (P)

Department of Biomedical Sciences, University of Padova, Italy.

Toren Finkel (T)

Center for Molecular Medicine, NHLBI, NIH, Bethesda, MD, USA.

Elizabeth Murphy (E)

Cardiovascular Branch, NHLBI, NIH, 10 Center Drive Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH